BUFFALO GROVE, Ill.--(BUSINESS WIRE)--Dec. 14, 2005--Akorn, Inc. (AMEX:AKN) today announced the results from the latest FDA inspection of the Decatur, IL manufacturing facility. In correspondence received on December 13, 2005 from the Chicago District of the FDA, the FDA reported the satisfactory resolution of past cGMP issues and that the Decatur manufacturing facility is in compliance with current good manufacturing practice regulations. As a result of this inspection, Akorn is now eligible for new product approvals at the Decatur, IL manufacturing facility.
